Alkem Laboratories Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

Alkem Laboratories has announced a board meeting on 29 May 2025, approving the consolidated financial results for the quarter and financial year. FY25 revenue rose to ₹12,964 Cr with net profit jumping to ₹2,215 Cr from ₹1,811 Cr in FY24. Operating profit hit ₹2,527 Cr. The board proposed a final dividend of ₹8 per share, joining the interim ₹37 declared earlier. Strategic updates include appointing two independent directors and progressing the carve-out of its generic business into a wholly-owned subsidiary. Robust cash flow and portfolio focus are driving growth.